2013 Q4 Form 10-K Financial Statement

#000137633914000005 Filed on March 04, 2014

View on sec.gov

Income Statement

Concept 2013 Q4 2013 2012 Q4
Revenue $17.99M $59.18M $10.51M
YoY Change 71.22% 118.76% 298.75%
Cost Of Revenue $3.110M $9.328M $1.690M
YoY Change 84.02% 79.8% 83.7%
Gross Profit $14.88M $49.85M $8.820M
YoY Change 68.74% 128.0% 413.05%
Gross Profit Margin 82.71% 84.24% 83.93%
Selling, General & Admin $14.28M $46.23M $8.150M
YoY Change 75.21% 135.96% 279.07%
% of Gross Profit 95.95% 92.73% 92.4%
Research & Development $1.380M $4.843M $1.140M
YoY Change 21.05% 67.87% 72.73%
% of Gross Profit 9.27% 9.71% 12.93%
Depreciation & Amortization $480.0K $637.0K $380.0K
YoY Change 26.32% 36.99% -17.39%
% of Gross Profit 3.23% 1.28% 4.31%
Operating Expenses $15.93M $51.07M $9.790M
YoY Change 62.72% 127.22% 135.9%
Operating Profit -$1.047M -$2.639M -$970.0K
YoY Change 7.94% -50.73% -60.1%
Interest Expense -$10.00K $45.00K -$630.0K
YoY Change -98.41% -92.41% 350.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.420M -$4.012M -$1.610M
YoY Change -11.8% -47.64% -37.6%
Income Tax $0.00 $100.0K $0.00
% Of Pretax Income
Net Earnings -$1.427M -$4.112M -$1.605M
YoY Change -11.09% -46.34% -37.72%
Net Earnings / Revenue -7.93% -6.95% -15.27%
Basic Earnings Per Share -$0.01 -$0.04 -$0.01
Diluted Earnings Per Share -$0.01 -$0.04 -$0.01
COMMON SHARES
Basic Shares Outstanding 97.85M shares 96.29M shares
Diluted Shares Outstanding 96.29M shares

Balance Sheet

Concept 2013 Q4 2013 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $44.10M $44.10M $6.800M
YoY Change 548.53% 548.53% 65.85%
Cash & Equivalents $44.08M $44.10M $6.754M
Short-Term Investments
Other Short-Term Assets $1.300M $1.300M $700.0K
YoY Change 85.71% 85.71% 250.0%
Inventory $3.881M $3.900M $3.023M
Prepaid Expenses
Receivables $16.09M $16.10M $7.654M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $65.39M $65.40M $18.09M
YoY Change 261.49% 261.33% 162.16%
LONG-TERM ASSETS
Property, Plant & Equipment $4.086M $4.100M $1.072M
YoY Change 281.29% 272.73% 19.07%
Goodwill $4.040M $4.040M
YoY Change -0.01%
Intangibles $11.18M $11.91M
YoY Change -6.15% -21.06%
Long-Term Investments
YoY Change
Other Assets $0.00 $70.00K
YoY Change -100.0% -65.0%
Total Long-Term Assets $19.31M $19.30M $17.09M
YoY Change 12.94% 12.87% -15.38%
TOTAL ASSETS
Total Short-Term Assets $65.39M $65.40M $18.09M
Total Long-Term Assets $19.31M $19.30M $17.09M
Total Assets $84.69M $84.70M $35.18M
YoY Change 140.73% 140.63% 29.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.491M $2.500M $1.252M
YoY Change 98.97% 92.31% -16.55%
Accrued Expenses $1.406M $7.000M $990.7K
YoY Change 41.92% 89.19% 23.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.608M $9.600M $5.017M
YoY Change 91.5% 92.0% 6.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $4.012M
YoY Change -100.0% -100.0% 48.61%
Other Long-Term Liabilities $1.518M $1.500M $353.3K
YoY Change 329.62% -75.41% -95.41%
Total Long-Term Liabilities $1.518M $1.500M $4.366M
YoY Change -65.23% -85.15% -58.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.608M $9.600M $5.017M
Total Long-Term Liabilities $1.518M $1.500M $4.366M
Total Liabilities $11.13M $11.10M $15.18M
YoY Change -26.68% -26.97% -0.16%
SHAREHOLDERS EQUITY
Retained Earnings -$73.80M -$69.68M
YoY Change 5.9%
Common Stock $104.0K $88.42K
YoY Change 17.62%
Preferred Stock
YoY Change
Treasury Stock (at cost) $25.00K $25.00K
YoY Change 0.0%
Treasury Stock Shares 50.00K shares 50.00K shares
Shareholders Equity $73.57M $73.60M $20.01M
YoY Change
Total Liabilities & Shareholders Equity $84.69M $84.70M $35.18M
YoY Change 140.73% 140.63% 29.83%

Cashflow Statement

Concept 2013 Q4 2013 2012 Q4
OPERATING ACTIVITIES
Net Income -$1.427M -$4.112M -$1.605M
YoY Change -11.09% -46.34% -37.72%
Depreciation, Depletion And Amortization $480.0K $637.0K $380.0K
YoY Change 26.32% 36.99% -17.39%
Cash From Operating Activities $830.0K -$284.0K -$870.0K
YoY Change -195.4% -91.48% -47.27%
INVESTING ACTIVITIES
Capital Expenditures -$500.0K -$3.030M -$240.0K
YoY Change 108.33% 373.44% 242.86%
Acquisitions $0.00
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$500.0K -$3.026M -$240.0K
YoY Change 108.33% 375.04% -233.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 37.66M $40.63M 240.0K
YoY Change 15591.67% 514.74% -95.15%
NET CHANGE
Cash From Operating Activities 830.0K -$284.0K -870.0K
Cash From Investing Activities -500.0K -$3.026M -240.0K
Cash From Financing Activities 37.66M $40.63M 240.0K
Net Change In Cash 37.99M $37.32M -870.0K
YoY Change -4466.67% 1313.25% -125.0%
FREE CASH FLOW
Cash From Operating Activities $830.0K -$284.0K -$870.0K
Capital Expenditures -$500.0K -$3.030M -$240.0K
Free Cash Flow $1.330M $2.746M -$630.0K
YoY Change -311.11% -202.01% -60.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89627601 USD
CY2012Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1251684 USD
CY2013Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
2490531 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7653561 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16092836 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1405974 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
990697 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2301870 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2279840 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
147284219 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
2715552 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2538721 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6009176 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1659083 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
47733 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
14885 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2538721 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6009176 USD
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1659083 USD
CY2011 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
27236 USD
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
20449 USD
CY2013 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1328439 USD
CY2011 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
315152 USD
CY2012 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1714101 USD
CY2011 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1335908 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1053971 USD
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22056948 shares
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1380241 USD
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27372173 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16660776 shares
CY2012Q4 us-gaap Assets
Assets
35182608 USD
CY2013Q4 us-gaap Assets
Assets
84693893 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
65388771 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
18088791 USD
CY2011 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2012 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
84650 USD
CY2013 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
355144 USD
CY2011 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
33583 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44077751 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6754485 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4112326 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1340922 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2771404 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
37323266 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2642159 USD
CY2010Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2013Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
43600000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
130000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
130000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88423169 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
104425614 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
88373169 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
104375614 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
88423 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
104426 USD
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Market Concentrations and Credit Risk</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company places its cash and cash equivalents on deposit with financial institutions in the United States.&#160;&#160;In July 2010, the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) increased coverage to </font><font style="font-family:inherit;font-size:10pt;">$250,000</font><font style="font-family:inherit;font-size:10pt;"> for substantially all depository accounts. As of December 31, 2013, the Company had cash and cash equivalents of approximately </font><font style="font-family:inherit;font-size:10pt;">$43,600,000</font><font style="font-family:inherit;font-size:10pt;"> in excess of the insured amounts.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s principal market concentration of risk is related to its limited distribution channels.&#160; The Company's revenues include the distribution efforts of several independent companies as well as the Company's internal sales force. Significant revenues are derived from its relationships with </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> of its distributors, AvKARE, Inc. which sells our products to the Federal government and another distributor that sells our products in certain defined Territories. For the years ended December 31, 2013, 2012 and 2011, AvKARE revenue was </font><font style="font-family:inherit;font-size:10pt;">56%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">40%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">0%</font><font style="font-family:inherit;font-size:10pt;"> of total revenue, respectively. Related receivables for the same time periods were </font><font style="font-family:inherit;font-size:10pt;">55%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">53%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">0%</font><font style="font-family:inherit;font-size:10pt;">, of total accounts receivable, respectively. For the years ended December 31, 2013, 2012 and 2011, the other distributor's revenue was </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">19%</font><font style="font-family:inherit;font-size:10pt;"> of total revenue, respectively. Related receivables for the same time periods were </font><font style="font-family:inherit;font-size:10pt;">12%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">33%</font><font style="font-family:inherit;font-size:10pt;"> of total accounts receivable, respectively.</font></div></div>
CY2013Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2013Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0 USD
CY2012Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5313645 USD
CY2011 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
80000 USD
CY2012 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
514456 USD
CY2013Q4 us-gaap Contractual Obligation
ContractualObligation
6430141 USD
CY2013Q4 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
1421135 USD
CY2013Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
1379877 USD
CY2013Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
869841 USD
CY2013Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
1300289 USD
CY2013Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
1339418 USD
CY2012Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
4012442 USD
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5188378 USD
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3357909 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
9328114 USD
CY2013 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
0 USD
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 USD
CY2012Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1301203 USD
CY2012Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
3000 USD
CY2013Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
1000 USD
CY2013Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1021000 USD
CY2012Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1117000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
18368303 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
20244000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3805
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15539000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14663000 USD
CY2012Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
89000 USD
CY2013Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
-507000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1369000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1407356 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
213000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2151000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
-125000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1404000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20244000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18368303 USD
CY2013 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2013 us-gaap Depreciation
Depreciation
637246 USD
CY2011 us-gaap Depreciation
Depreciation
446502 USD
CY2012 us-gaap Depreciation
Depreciation
465367 USD
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2011Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2011Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0248
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4673
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.1273
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0065
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0340
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.0248
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2753237 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5588811 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
14882616 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
11316261 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
2746953 USD
CY2012Q4 us-gaap Gross Profit
GrossProfit
8820402 USD
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
12052935 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5740131 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
923935 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
824335 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
834302 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
923935 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
923935 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10170573 USD
CY2012 us-gaap Gain Loss On Disposition Of Property
GainLossOnDispositionOfProperty
0 USD
CY2013 us-gaap Gain Loss On Disposition Of Property
GainLossOnDispositionOfProperty
-36800 USD
CY2011 us-gaap Gain Loss On Disposition Of Property
GainLossOnDispositionOfProperty
0 USD
CY2013Q4 us-gaap Goodwill
Goodwill
4040443 USD
CY2012Q4 us-gaap Goodwill
Goodwill
4040443 USD
CY2013 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
30000 USD
CY2011 us-gaap Gross Profit
GrossProfit
4402537 USD
CY2013 us-gaap Gross Profit
GrossProfit
49852620 USD
CY2012 us-gaap Gross Profit
GrossProfit
21865395 USD
CY2011Q3 us-gaap Gross Profit
GrossProfit
1265584 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
3769330 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
6528710 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
14002270 USD
CY2011Q1 us-gaap Gross Profit
GrossProfit
333370 USD
CY2011Q2 us-gaap Gross Profit
GrossProfit
1084458 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
9651473 USD
CY2011Q4 us-gaap Gross Profit
GrossProfit
1719125 USD
CY2013Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
368000 USD
CY2012 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1800000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4012239 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10193986 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7662376 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
99614 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
61129 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1208747 USD
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
732938 USD
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-81112 USD
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1208456 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8439275 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5761642 USD
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
605856 USD
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
352881 USD
CY2011 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
328379 USD
CY2013 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
2835574 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
3022784 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
3880776 USD
CY2012 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
2354888 USD
CY2011 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
194934 USD
CY2011 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
107886 USD
CY2012 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
387896 USD
CY2013 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-41641 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
857992 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
253942 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2310182 USD
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-70000 USD
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-96657 USD
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
80375 USD
CY2011 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
16383 USD
CY2012 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
40840 USD
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-28969 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
466060 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
70980 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
706683 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11911749 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11178573 USD
CY2012 us-gaap Interest Expense
InterestExpense
592892 USD
CY2013 us-gaap Interest Expense
InterestExpense
45233 USD
CY2011 us-gaap Interest Expense
InterestExpense
117818 USD
CY2013 us-gaap Interest Paid
InterestPaid
36202 USD
CY2011 us-gaap Interest Paid
InterestPaid
15456 USD
CY2012 us-gaap Interest Paid
InterestPaid
13322 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1048886 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1349121 USD
CY2012Q4 us-gaap Inventory Gross
InventoryGross
3181405 USD
CY2013Q4 us-gaap Inventory Gross
InventoryGross
4203004 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
233747 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
202414 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
158621 USD
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
322228 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1598537 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2951704 USD
CY2011 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
488000 USD
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
485000 USD
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1000000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
11125823 USD
CY2012Q4 us-gaap Liabilities
Liabilities
15175306 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35182608 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84693893 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5017201 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9607867 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4012442 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2013 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of Business</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">MiMedx Group, Inc. (&#8220;MiMedx,&#8221; "the Company,&#8221; &#8220;we,&#8221; or &#8220;us&#8221;) operates in </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> business segment, Regenerative Biomaterials, which includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories.&#160;&#160;Our biomaterial platform technologies include tissue technologies, AmnioFix&#174; and EpiFix&#174;, and device technology CollaFix</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#8482;</sup></font><font style="font-family:inherit;font-size:10pt;"> .</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is focused primarily on the United States but will pursue other individual markets based upon the specific opportunity.&#160;&#160;The adoption of the technologies may vary depending on each country&#8217;s regulations, but the opportunities to help individuals in the different disease states remain similar and large.</font></div></div>
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6609921 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10138683 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40634157 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3025414 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-636502 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-702508 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3331260 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6664771 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-285477 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-10193986 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-7662376 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-4111853 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-1426938 USD
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-3347562 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-4219372 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-1765723 USD
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-2503505 USD
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
-2577196 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-1620408 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-307118 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-757389 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-1605283 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-744069 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-1093652 USD
CY2013 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Business_Segment
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-2638567 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-5355383 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-9761016 USD
CY2013 us-gaap Operating Loss Carryforwards Expiration Dates
OperatingLossCarryforwardsExpirationDates
2027 and 2033
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
70000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
122551 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
21583 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
353333 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1517956 USD
CY2012 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
568 USD
CY2011 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
0 USD
CY2013 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
0 USD
CY2011 us-gaap Payments For Tenant Improvements
PaymentsForTenantImprovements
0 USD
CY2013 us-gaap Payments For Tenant Improvements
PaymentsForTenantImprovements
996866 USD
CY2012 us-gaap Payments For Tenant Improvements
PaymentsForTenantImprovements
0 USD
CY2013 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
101694 USD
CY2011 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2012 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2011 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
466417 USD
CY2013 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2012 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2011 us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
0 USD
CY2013 us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
57450 USD
CY2012 us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
16116 USD
CY2013 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
2336517 USD
CY2012 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
636502 USD
CY2011 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
486091 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1337408 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
657961 USD
CY2013 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Certain amounts in the prior year financial statements have been reclassified to conform to the current year financial statement presentation.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>
CY2011 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
3730587 USD
CY2013 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
CY2012 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
CY2012 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
CY2013 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
CY2011 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
1250000 USD
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
36602306 USD
CY2012 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
CY2011 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
CY2011 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
5000000 USD
CY2012 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
0 USD
CY2013 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
0 USD
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1052668 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1981418 USD
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
295753 USD
CY2012 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
6001063 USD
CY2013 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2107883 USD
CY2011 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3351465 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6387976 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4086106 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1071625 USD
CY2011Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2152094 USD
CY2013 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
70141 USD
CY2012 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
201812 USD
CY2011 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
92565 USD
CY2012 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
427126 USD
CY2013 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2011 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2011 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
99000 USD
CY2012 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2013 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2013 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2011 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7760446 USD
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
59180734 USD
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
27053773 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
11556493 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
16115708 USD
CY2013Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
17993790 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4884256 USD
CY2011Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1043487 USD
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3705808 USD
CY2011Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2635466 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
13514743 USD
CY2011 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
88657 USD
CY2012 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2976313 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2884546 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4843457 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73795575 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69683722 USD
CY2013 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Grant Income</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company received a Regional Economic Business Assistance ("REBA") grant in the amount of </font><font style="font-family:inherit;font-size:10pt;">$250,000</font><font style="font-family:inherit;font-size:10pt;"> from the State of Georgia to help the Company defray certain expenses and capital expenditures related to the Company's expansion of manufacturing activities in the State.&#160;&#160;In order to retain the grant monies the Company was required to add a certain number of full time positions and spend a certain amount on capital and operations expenditures by December 31, 2014. As of December 31, 2013, the Company had satisfied the grant requirements. Accordingly, the Company has recorded the </font><font style="font-family:inherit;font-size:10pt;">$250,000</font><font style="font-family:inherit;font-size:10pt;"> as a reduction of Selling, General and Administrative expenses in the accompanying Consolidated Statements of Operations. Previously, this amount was recorded as Deferred Grant Income and was included in Other Liabilities per ASC 450-30 Gain Contingencies.</font></div></div>
CY2013 us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sells its products primarily through a combination of a direct sales force, independent stocking distributors and third party representatives in the U.S. and independent distributors in international markets.&#160;&#160;The Company recognizes revenue when title to the goods and risk of loss transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance.&#160;&#160;In cases where the Company utilizes distributors or ships products directly to the end user, it recognizes revenue according to the shipping terms of the agreement provided all revenue recognition criteria have been met.&#160;&#160;A portion of the Company&#8217;s revenue is generated from inventory maintained at hospitals or with field representatives.&#160;&#160;For these products, revenue is recognized at the time the product has been used or implanted.&#160;&#160;The Company records estimated sales returns, discounts and allowances as a reduction of net sales in the same period revenue is recognized.</font></div></div>
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7954046 USD
CY2011Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1929399 USD
CY2012Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10509663 USD
CY2011 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9845529 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46225657 USD
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19590446 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
2538721 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
1659083 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
6009176 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0224
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0188
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0177
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0062
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0086
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0085
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
6000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
22500000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
15081653 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.33
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
718978 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8864115 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
258000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
35499 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
265002 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4021000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.63
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.08
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.07
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
96614260 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13614135 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15375960 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.42
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.46
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
95324825 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
6807732 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.42
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
50441475 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue
1194000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue
3351000 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue
1851000 USD
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.01
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.11
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.47
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.31
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
6807732 shares
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
15375960 shares
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y6M
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y8M12D
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
1.33
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
2.46
CY2013 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y8M12D
CY2012 us-gaap Stock Issued1
StockIssued1
0 USD
CY2011 us-gaap Stock Issued1
StockIssued1
7087500 USD
CY2013 us-gaap Stock Issued1
StockIssued1
0 USD
CY2011 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
893267 shares
CY2013 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
893267 shares
CY2012 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
893267 shares
CY2013 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
5272004 shares
CY2011 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
406664 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1958674 shares
CY2012 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
893267 USD
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5272004 USD
CY2011 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
406663 USD
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
36509810 USD
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3730587 USD
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1052668 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
295753 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1981418 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
20007302 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
73568070 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
11896565 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
6100528 USD
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
50000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
50000 shares
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
25000 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
25000 USD
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with generally accepted accounting principles (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported consolidated statements of operations during the reporting period.&#160;&#160;Actual results could differ from those estimates.</font></div></div>
CY2011 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2012 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2013 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72450337 shares
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96285504 shares
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81646295 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
96285504 shares
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
81646295 shares
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72450337 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81646295 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96285504 shares
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72450337 shares
CY2012 mdxg Adjustments To Additional Paid In Capital Related Party
AdjustmentsToAdditionalPaidInCapitalRelatedParty
514456 USD
CY2011 mdxg Adjustments To Additional Paid In Capital Related Party
AdjustmentsToAdditionalPaidInCapitalRelatedParty
80000 USD
CY2011 mdxg Beneficial Conversion Feature Related To Warrants Issued With Regard To Senior Secured Promissory Notes
BeneficialConversionFeatureRelatedToWarrantsIssuedWithRegardToSeniorSecuredPromissoryNotes
14885 USD
CY2013 mdxg Beneficial Conversion Feature Related To Warrants Issued With Regard To Senior Secured Promissory Notes
BeneficialConversionFeatureRelatedToWarrantsIssuedWithRegardToSeniorSecuredPromissoryNotes
0 USD
CY2012 mdxg Beneficial Conversion Feature Related To Warrants Issued With Regard To Senior Secured Promissory Notes
BeneficialConversionFeatureRelatedToWarrantsIssuedWithRegardToSeniorSecuredPromissoryNotes
0 USD
CY2012 mdxg Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
216 USD
CY2011 mdxg Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
0 USD
CY2013 mdxg Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
0 USD
CY2013Q4 mdxg Contractual Obligation Due After Second Year
ContractualObligationDueAfterSecondYear
119581 USD
CY2011 mdxg Convertible Debt Issued In Acquisition Of Company
ConvertibleDebtIssuedInAcquisitionOfCompany
437500 USD
CY2012 mdxg Convertible Debt Issued In Acquisition Of Company
ConvertibleDebtIssuedInAcquisitionOfCompany
0 USD
CY2013 mdxg Convertible Debt Issued In Acquisition Of Company
ConvertibleDebtIssuedInAcquisitionOfCompany
0 USD
CY2012Q4 mdxg Deferred Tax Assets Contingent Consideration
DeferredTaxAssetsContingentConsideration
567947 USD
CY2013Q4 mdxg Deferred Tax Assets Contingent Consideration
DeferredTaxAssetsContingentConsideration
0 USD
CY2012Q4 mdxg Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
6000 USD
CY2013Q4 mdxg Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
142000 USD
CY2012Q4 mdxg Deferred Tax Liability Debt Instrument Convertible Beneficial Conversion Feature
DeferredTaxLiabilityDebtInstrumentConvertibleBeneficialConversionFeature
449000 USD
CY2013Q4 mdxg Deferred Tax Liability Debt Instrument Convertible Beneficial Conversion Feature
DeferredTaxLiabilityDebtInstrumentConvertibleBeneficialConversionFeature
0 USD
CY2013 mdxg Defined Benefit Plan Maximum Pre Tax Contributions By Plan Participants
DefinedBenefitPlanMaximumPreTaxContributionsByPlanParticipants
5500 USD
CY2013 mdxg Defined Contribution Plan Maximum Percentage Of Eligible Wages Deferred By Participants
DefinedContributionPlanMaximumPercentageOfEligibleWagesDeferredByParticipants
1
CY2013Q4 mdxg Earn Out Liability Payable In Mimedx Stock
EarnOutLiabilityPayableInMimedxStock
0 USD
CY2012Q4 mdxg Earn Out Liability Payable In Mimedx Stock
EarnOutLiabilityPayableInMimedxStock
5792330 USD
CY2013 mdxg Fair Value Adjustment Of Earn Out Liability
FairValueAdjustmentOfEarn-OutLiability
0 USD
CY2012 mdxg Fair Value Adjustment Of Earn Out Liability
FairValueAdjustmentOfEarn-OutLiability
1567050 USD
CY2011 mdxg Fair Value Adjustment Of Earn Out Liability
FairValueAdjustmentOfEarn-OutLiability
5803 USD
CY2012 mdxg Fair Value Adjustment Of Earn Out Liability
FairValueAdjustmentOfEarnOutLiability
1567050 USD
CY2011 mdxg Fair Value Adjustment Of Earn Out Liability
FairValueAdjustmentOfEarnOutLiability
5803 USD
CY2013 mdxg Fair Value Adjustment Of Earn Out Liability
FairValueAdjustmentOfEarnOutLiability
0 USD
CY2011 mdxg Impairment Of Intangible Assets
ImpairmentOfIntangibleAssets
0 USD
CY2013 mdxg Impairment Of Intangible Assets
ImpairmentOfIntangibleAssets
368102 USD
CY2012 mdxg Impairment Of Intangible Assets
ImpairmentOfIntangibleAssets
1798495 USD
CY2012Q4 mdxg Intangible Assets Accumulated Amortization And Impairment Charges
IntangibleAssetsAccumulatedAmortizationAndImpairmentCharges
6647251 USD
CY2013Q4 mdxg Intangible Assets Accumulated Amortization And Impairment Charges
IntangibleAssetsAccumulatedAmortizationAndImpairmentCharges
8069324 USD
CY2012Q4 mdxg Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
18559000 USD
CY2011 mdxg Noncash Stock Issued Acquisition
NoncashStockIssuedAcquisition
2278052 USD
CY2013 mdxg Noncash Stock Issued Acquisition
NoncashStockIssuedAcquisition
0 USD
CY2013Q4 mdxg Number Of Major Customers
NumberOfMajorCustomers
2 distributor
CY2013 mdxg Share Based Compensation Arrangement By Share Based Payment Award Stock Options Cancelled Or Expired In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsCancelledOrExpiredInPeriod
265002 shares
CY2013Q4 mdxg Long Term Debt Including Related Party Current Maturities
LongTermDebtIncludingRelatedPartyCurrentMaturities
0 USD
CY2013 mdxg Maximum Eligible Wages Deferred By Participants Per Year
MaximumEligibleWagesDeferredByParticipantsPerYear
17500 USD
CY2013 mdxg Minimum Age For Additional Contribution Beyond Normal Plan
MinimumAgeForAdditionalContributionBeyondNormalPlan
P50Y
CY2013 mdxg Minimum Age Require To Qualify For Pension Plan
MinimumAgeRequireToQualifyForPensionPlan
P21Y
CY2013 mdxg Minimum Service Period Require To Qualify For Pension Plan
MinimumServicePeriodRequireToQualifyForPensionPlan
P3M
CY2012 mdxg Noncash Stock Issued Acquisition
NoncashStockIssuedAcquisition
893267 USD
CY2013Q4 mdxg Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
19247897 USD
CY2012Q4 mdxg Long Term Debt Including Related Party Current Maturities
LongTermDebtIncludingRelatedPartyCurrentMaturities
0 USD
CY2013 mdxg Number Of Share Based Compensation Plans
NumberOfShareBasedCompensationPlans
3 plan
CY2013Q4 mdxg Outstanding Assumed Options
OutstandingAssumedOptions
375000 shares
CY2012 mdxg Paymentsfor Application Costs Patent
PaymentsforApplicationCostsPatent
0 USD
CY2013 mdxg Paymentsfor Application Costs Patent
PaymentsforApplicationCostsPatent
688897 USD
CY2011 mdxg Paymentsfor Application Costs Patent
PaymentsforApplicationCostsPatent
0 USD
CY2011 mdxg Proceeds From Line Of Credit With Related Party
ProceedsFromLineOfCreditWithRelatedParty
1300000 USD
CY2013 mdxg Proceeds From Line Of Credit With Related Party
ProceedsFromLineOfCreditWithRelatedParty
0 USD
CY2012 mdxg Proceeds From Line Of Credit With Related Party
ProceedsFromLineOfCreditWithRelatedParty
0 USD
CY2013 mdxg Proceeds From Reba Grant
ProceedsFromRebaGrant
0 USD
CY2011 mdxg Proceeds From Reba Grant
ProceedsFromRebaGrant
250000 USD
CY2012 mdxg Proceeds From Reba Grant
ProceedsFromRebaGrant
0 USD
CY2012 mdxg Repurchase Of Warrants
RepurchaseOfWarrants
568 USD
CY2013 mdxg Share Based Compensation Arrangement By Share Based Payment Award Stock Options Cancelled Or Expired Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsCancelledOrExpiredWeightedAverageGrantDateFairValue
2.14
CY2013 mdxg Share Based Compensation Arrangement By Share Based Payment Award Stock Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantsInPeriod
4021000 shares
CY2013 mdxg Share Based Compensation Arrangement By Share Based Payment Award Stock Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.08
CY2013Q4 mdxg Share Based Compensation Arrangement By Share Based Payment Award Stock Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedNumber
8568228 shares
CY2012Q4 mdxg Share Based Compensation Arrangement By Share Based Payment Award Stock Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedNumber
8377538 shares
CY2013Q4 mdxg Share Based Compensation Arrangement By Share Based Payment Award Stock Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedWeightedAverageGrantDateFairValue
1.94
CY2012Q4 mdxg Share Based Compensation Arrangement By Share Based Payment Award Stock Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedWeightedAverageGrantDateFairValue
0.96
CY2013 mdxg Share Based Compensation Arrangement By Share Based Payment Award Stock Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedInPeriod
3565308 shares
CY2013 mdxg Share Based Compensation Arrangement By Share Based Payment Award Stock Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.94
CY2011 mdxg Shares Issued In Conjunction With Its Acquisition Of Company
SharesIssuedInConjunctionWithItsAcquisitionOfCompany
5250000 shares
CY2012 mdxg Stock Issued During Period Shares Accrued Director Fees
StockIssuedDuringPeriodSharesAccruedDirectorFees
167086 shares
CY2012 mdxg Stock Issued During Period Shares Cashless Exercise
StockIssuedDuringPeriodSharesCashlessExercise
216085 shares
CY2013 mdxg Stock Issued During Period Shares For Earn Out Liability
StockIssuedDuringPeriodSharesForEarnOutLiability
1174915 shares
CY2012 mdxg Stock Issued During Period Shares For Earn Out Liability
StockIssuedDuringPeriodSharesForEarnOutLiability
2632576 shares
CY2012 mdxg Stock Issued During Period Shares Issued For Payment Of Line Of Credit With Related Party
StockIssuedDuringPeriodSharesIssuedForPaymentOfLineOfCreditWithRelatedParty
1403630 shares
CY2011 mdxg Stock Issued During Period Value Acquisitions Company
StockIssuedDuringPeriodValueAcquisitionsCompany
7087500 USD
CY2012 mdxg Stock Issued During Period Value Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
0 USD
CY2012 mdxg Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
6001063 USD
CY2013 mdxg Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
2107883 USD
CY2012 mdxg Stock Issued During Period Value For Accrued Director Fees
StockIssuedDuringPeriodValueForAccruedDirectorFees
184653 USD
CY2013 mdxg Stock Issued During Period Value For Accrued Director Fees
StockIssuedDuringPeriodValueForAccruedDirectorFees
0 USD
CY2011 mdxg Stock Issued During Period Value For Accrued Director Fees
StockIssuedDuringPeriodValueForAccruedDirectorFees
0 USD
CY2012 mdxg Stock Issued During Period Value For Earn Out Liability
StockIssuedDuringPeriodValueForEarnOutLiability
3185223 USD
CY2013 mdxg Stock Issued During Period Value For Earn Out Liability
StockIssuedDuringPeriodValueForEarnOutLiability
5792330 USD
CY2011 mdxg Stock Issued During Period Value For Earn Out Liability
StockIssuedDuringPeriodValueForEarnOutLiability
0 USD
CY2012 mdxg Stock Issued During Period Value Issued For Payment Of Line Of Credit With Related Party
StockIssuedDuringPeriodValueIssuedForPaymentOfLineOfCreditWithRelatedParty
1403630 USD
CY2013 mdxg Stock Issued During Period Value Issued For Payment Of Line Of Credit With Related Party
StockIssuedDuringPeriodValueIssuedForPaymentOfLineOfCreditWithRelatedParty
0 USD
CY2011 mdxg Stock Issued During Period Value Issued For Payment Of Line Of Credit With Related Party
StockIssuedDuringPeriodValueIssuedForPaymentOfLineOfCreditWithRelatedParty
0 USD
CY2013 mdxg Warrants Term
WarrantsTerm
P5Y
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001376339
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
105581111 shares
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q2 dei Entity Public Float
EntityPublicFloat
559000000 USD
CY2013 dei Entity Registrant Name
EntityRegistrantName
MIMEDX GROUP, INC.
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No

Files In Submission

Name View Source Status
0001376339-14-000005-index-headers.html Edgar Link pending
0001376339-14-000005-index.html Edgar Link pending
0001376339-14-000005.txt Edgar Link pending
0001376339-14-000005-xbrl.zip Edgar Link pending
comparisonofcumulativetotalr.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mdxg-20131231.xml Edgar Link completed
mdxg-20131231.xsd Edgar Link pending
mdxg-2013123110xkex105nqag.htm Edgar Link pending
mdxg-20131231x10k.htm Edgar Link pending
mdxg-20131231x10xkex103rsa.htm Edgar Link pending
mdxg-20131231x10xkex104iso.htm Edgar Link pending
mdxg-20131231x10xkex231con.htm Edgar Link pending
mdxg-20131231x10xkex311.htm Edgar Link pending
mdxg-20131231x10xkex312.htm Edgar Link pending
mdxg-20131231x10xkex321.htm Edgar Link pending
mdxg-20131231x10xkex322.htm Edgar Link pending
mdxg-20131231_cal.xml Edgar Link unprocessable
mdxg-20131231_def.xml Edgar Link unprocessable
mdxg-20131231_lab.xml Edgar Link unprocessable
mdxg-20131231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending